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Abstract: BACKGROUND Diagnostic evaluation of febrile young infants is challenging. Empirical an-
timicrobial treatment is therefore common practice in this setting despite high percentage of causative
viral infections. The objective of this study was to investigate the impact of rapid enterovirus cere-
brospinal fluid polymerase chain reaction (CSF EV PCR) test on hospital length of stay (LOS) and
antimicrobial treatment duration in young febrile infants. METHODS Retrospective observational study
comparing duration of antimicrobial treatment and hospital LOS before (May 1, 2014 - May 30, 2015,
untested group) and after (June 1, 2015 - June 30, 2017, tested group) the introduction of rapid CSF
EV PCR testing in infants < 90 days of age presenting with fever and CSF pleocytosis at the Univer-
sity Children’s Hospital Zurich. Additionally, the same variables were compared after test introduction
between CSF EV PCR positive and negative children. RESULTS One hundred twenty-eight children
were enrolled in the study, 58 before and 70 after the introduction of rapid CSF EV PCR testing. Du-
ration of antimicrobial treatment was significantly shortened in EV positive (n = 42) compared to both
EV negative (n = 28) (median 18 h and 48 h, respectively, p < 0.001) and untested patients (n = 58)
(median 18 h and 48 h, respectively, p < 0.001), and also in tested compared to untested group patients
(median 36 vs 48 h, p < 0.001). Hospital LOS was significantly shortened in EV positive compared to
EV negative patients (median 3 days and 4 days respectively, p = 0.013), while an overall reduction was
not observed between tested and untested group patients. CONCLUSIONS In this study we demonstrate
that antimicrobial treatment duration could be significantly shortened in neonates and young infants <
90 days of age with aseptic meningitis after the introduction of a rapid CSF EV PCR test compared to
untested patients before test introduction.
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Abstract
Background: Diagnostic evaluation of febrile young infants is challenging. Empirical antimicrobial treatment is
therefore common practice in this setting despite high percentage of causative viral infections. The objective of this
study was to investigate the impact of rapid enterovirus cerebrospinal fluid polymerase chain reaction (CSF EV PCR)
test on hospital length of stay (LOS) and antimicrobial treatment duration in young febrile infants.
Methods: Retrospective observational study comparing duration of antimicrobial treatment and hospital LOS
before (May 1, 2014 - May 30, 2015, untested group) and after (June 1, 2015 - June 30, 2017, tested group) the
introduction of rapid CSF EV PCR testing in infants < 90 days of age presenting with fever and CSF pleocytosis at
the University Children’s Hospital Zurich. Additionally, the same variables were compared after test introduction
between CSF EV PCR positive and negative children.
Results: One hundred twenty-eight children were enrolled in the study, 58 before and 70 after the introduction of
rapid CSF EV PCR testing. Duration of antimicrobial treatment was significantly shortened in EV positive (n = 42)
compared to both EV negative (n = 28) (median 18 h and 48 h, respectively, p < 0.001) and untested patients (n =
58) (median 18 h and 48 h, respectively, p < 0.001), and also in tested compared to untested group patients
(median 36 vs 48 h, p < 0.001). Hospital LOS was significantly shortened in EV positive compared to EV negative
patients (median 3 days and 4 days respectively, p = 0.013), while an overall reduction was not observed between
tested and untested group patients.
Conclusions: In this study we demonstrate that antimicrobial treatment duration could be significantly shortened
in neonates and young infants < 90 days of age with aseptic meningitis after the introduction of a rapid CSF EV
PCR test compared to untested patients before test introduction.
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Background
The diagnostic evaluation of febrile young infants (< 90
days of age) is challenging. Clinical and laboratory find-
ings at presentation do not allow to reliably identify and
treat only those with serious bacterial infections [1–3].
Neonates and young infants with fever are therefore fre-
quently hospitalized and empirically treated with paren-
teral broad-spectrum antibiotics until bacterial culture
results are available [2, 4]. However, most of these pa-
tients suffer from viral infections [2]. Enteroviruses (EV)
are found in 25–60% of febrile infants < 90 days of age
and are the main cause of aseptic meningitis, not only in
summer and fall but even during offseason [5–8]. Never-
theless, the diagnosis of EV meningitis remains challen-
ging: first, because cerebrospinal fluid (CSF) pleocytosis
and polymorphonuclear cells predominance in CSF do
not allow to certainly discriminate between viral and
bacterial etiology, and second, because CSF pleocytosis
may be absent despite EV meningitis in up to 34% of fe-
brile infants < 90 days of age and in up to 77% of febrile
neonates [6, 9–12]. Rapid detection of EV in CSF by re-
verse transcription polymerase chain reaction (PCR) al-
lows accurate and rapid diagnosis of infants with EV
meningitis. CSF EV PCR testing has previously been
shown to decrease antimicrobial treatment duration and
hospital length of stay (LOS) in infants with aseptic men-
ingitis [4, 6, 10, 13–17]. However, these previous studies
investigated the impact of CSF EV PCR tests with results
available after 12 h and longer [6, 10, 14, 18], at any age
[10, 13, 15–17, 19–21], and/or restricted the study period
to summer and fall [15, 20]. Additionally patients were
exclusively compared depending on CSF EV PCR results
[6, 10, 13, 15], before and after the introduction of the test
[17], or without a proper control group [18–20].
The objective of this study was to investigate the impact
of a rapid CSF EV PCR with time to result of 3 to 6 h on
hospital LOS and duration of antimicrobial treatment in
children < 90 days of age with aseptic meningitis.
Methods
Study design
We performed a retrospective observational study at the
University Children’s Hospital of Zurich. Demographic,
clinical, and laboratory data including hospital LOS and
duration of antimicrobial treatment were extracted from
medical records and the microbiology laboratory database.
Patients
Previously healthy infants < 90 days of age (i.e. children
without any underlying condition) presenting at our
emergency department with fever (rectal temperature ≥
38.0 °C) were eligible for inclusion if they underwent
standardized full sepsis evaluation (consisting of analysis
of blood, catheter urine and CSF) prior to antimicrobial
treatment between May 1, 2014 and June 30, 2017. In
house rapid CSF EV PCR testing was introduced June 1,
2015. The test was not routinely applied to all febrile in-
fants under the age of 90 days. The attending physician
decided whether to perform the test based mainly on ex-
posure history, seasonality and the presence of CSF pleo-
cytosis. Infants presenting with fever and CSF
pleocytosis, defined as the presence of ≥5 white blood
cells (WBC) per μl, after test introduction (June 1, 2015
- June 30, 2017; 25 months) were included in the tested
group if they had CSF EV PCR performed at admission,
and those presenting within 13months before its intro-
duction (May 1, 2014 - May 30, 2015; 13 months) in the
untested group. Although the reported thresholds for
definition of CSF pleocytosis in children < 8 weeks may
be higher [22, 23], the definition of 5 WBC per μl CSF
was used as threshold for CSF EV PCR testing at our in-
stitution in order to avoid missing neonates with low or
absent CSF pleocytosis despite enteroviral meningitis as
described in previous studies [6, 9–12]. Since no bacter-
ial infections such as bacteremia, bacterial meningitis or
urinary tract infection (UTI) were observed in the tested
group patients, children with bacterial infections were
excluded also from the untested group to prevent bias
due to prolonged hospital LOS and antimicrobial treat-
ment associated with these conditions. Children with
bacterial contamination in blood, urine or CSF culture
on the other hand were not excluded from the analysis.
Bacterial contamination was defined as identification of
a common skin commensal (i.e. coagulase-negative
staphylococci including S. epidermidis, viridans group
streptococci, Bacillus spp., Propionibacterium spp., Cor-
ynebacterium spp., Aerococcus spp. and Micrococcus
spp.) in blood or CSF cultures or growth of 2 or more
bacteria in urine culture.
CSF EV PCR testing
CSF EV PCR was performed using the commercially
available Xpert® EV method (Cepheid, Sunnyvale, Cali-
fornia, USA). The assay runs on GeneXpert® system with
integrated sample processing, viral RNA extraction, re-
verse transcription (RT) and nucleic acid amplification,
as well as detection of the target sequence by real-time
PCR, in a single reaction cartridge. The following EV
species and subtypes are detected: Species A (Coxsackie
A2-A8, A10, A12, A14, A16, EV71), Species B (Cox-
sackie A9, B1-B6, Echo 1–7, 9, 11–21, 24–27, 29–33,
EV69), Species C (Coxsackie A11, A13, A15, A17–22,
A24), Species D (EV68, EV70) and Poliovirus (Poliovirus
1–3). The test has a running time of less than 2.5 h and
was available every day between 07:00 AM and midnight
in the in-house microbiology laboratory. During these
17 h, treating physicians were informed immediately
about the test results with a time to result of 3 to 6 h.
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CSF samples awaiting processing were kept at 4 °C until
testing.
Data analysis
Continuous data were described using median and inter-
quartile range (IQR), whereas categorical data were de-
scribed using frequency and percentage. Mann-Whitney
U test was used to compare medians between groups.
For the comparison of more than two groups Pearson
Chi-squared and Kruskal-Wallis tests were used for cat-
egorical and continuous data respectively. Subsequent
post hoc testing by pairwise comparisons was performed
in case of statistical significance in order to identify the
groups with significant differences. All analyses were
performed with IBM SPSS Statistics version 24. Two-
tailed p-values smaller than 0.05 were considered to be
statistically significant.
Results
During the three-year study period, a total of 228 previ-
ously healthy infants < 90 days of age presented with
fever and underwent full sepsis evaluation (Fig. 1). After
introducing CSF EV PCR testing, the test was performed
in 80 febrile infants < 90 days. Thereof, 7 patients were
excluded because CSF EV PCR was requested despite
the lack of pleocytosis (≥5 cells/μl CSF) and in 3 cases
the test failed and no result was available. Among the 70
patients included in the tested group, 42 (60%) were
tested positive by CSF EV PCR and no bacterial co-
infection (sepsis, bacterial meningitis, UTI) was docu-
mented. In the period before the introduction of CSF EV
PCR testing, 148 febrile patients < 90 days underwent full
sepsis evaluation. Thereof, 77 patients were excluded
due to lack of CSF pleocytosis and 13 due to presence of
bacterial infection. The remaining 58 patients were in-
cluded in the untested group. Demographic
Fig. 1 Study profile. Recruitment and flow of patients in untested group (left) and tested group (right). 1Pleocytosis defined as the presence of
≥5 white blood cells per μl in CSF. Abbreviations: EV, enterovirus; CSF, cerebrospinal fluid; PCR, polymerase chain reaction; UTI, urinary tract
infection; d, days
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characteristics and laboratory results of the patients are
shown in Table 1. Of note, while age, C-reactive protein
(CRP) and CSF glucose did not significantly differ in
CSF EV PCR-positive compared to negative and un-
tested group patients, a significantly higher level of CSF
leucocytes was found for CSF EV PCR positive
compared to negative patients (median 127 cells/μl and
17 cells/μl, respectively, p < 0.001).
Antimicrobial treatment duration was significantly
shortened by more than half in CSF EV PCR-positive
compared to both negative patients (median 18 h and
48 h, respectively, p < 0.001) and untested group patients
Table 1 Patients characteristics
Tested group Untested group
CSF EV PCR + CSF EV PCR - p-value1
Patients, n 42 28 58







Gender male, n (%) 24 (57.1%) 15 (53.6%) 34 (58.6%) 0.906








































Contamination rate overall, n (%)4 10 (23.8%) 10 (35.7%) 23 (39.7%) 0.245
Abbreviations: CSF cerebrospinal fluid, EV enterovirus, WBC white blood cells, CRP C-reactive protein, IQR interquartile range;
1 Pearson Chi-squared test for categorical data, Kruskal-Wallis test for continuous data
2 Statistically significant difference between CSF EV PCR + and – patients (p < 0.001) and between CSF EV PCR + and untested group patients (p = 0.011)
3 Statistically significant difference between CSF EV PCR + and untested group patients
4 Contamination defined as non-relevant bacterial growth in culture from blood, CSF and/or urine
Fig. 2 Median duration of antimicrobial treatment (a) and hospital LOS (b). Comparison of duration of antimicrobial treatment (a) and hospital
LOS (b) between CSF EV CSF PCR positive, negative and untested group patients using Kruskal-Wallis test. The number in the bars indicates the
median value. Abbreviations: LOS, length of stay; EV, enterovirus; CSF, cerebrospinal fluid; PCR, polymerase chain reaction; hrs, hours; d, days
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(median 18 h and 48 h, respectively, p < 0.001) (Fig. 2a).
Furthermore, the duration of antimicrobial treatment
was significantly shorter in the tested compared to the
untested group patients (median 36 vs 48 h, p < 0.001;
Fig. 3a).
Hospital LOS was significantly shorter in CSF EV PCR
positive compared to negative patients (median 3 days
and 4 days, respectively, p < 0.001 as shown in Fig. 2b
while an overall reduction was not observed between pa-
tients in the tested and untested group (4 days in both
groups, p = 0.537; Fig. 3b).
Bacterial contamination rates detected in cultures
from blood, CSF and urine did not differ between CSF
EV PCR positive, negative and untested group patients
(Table 1). The analysis of hospital LOS and duration of
antimicrobial treatment showed similar results after ex-
clusion of patients with contaminated bacterial cultures
(median duration of antimicrobial treatment 24 h in the
tested group vs. 48 h in the untested group, p < 0.001;
median hospital LOS 4 days in both groups, p = 0.117).
Discussion
In this observational study we demonstrate that anti-
microbial treatment duration could be significantly
shortened in neonates and young infants < 90 days of
age with aseptic meningitis at our institution after the
introduction of a rapid CSF EV PCR test compared to
untested patients before test introduction. This is mostly
due to the effect of the significant reduction of
antimicrobial treatment duration by more than 60% to a
median length of treatment of less than 24 h in EV posi-
tive compared to EV negative patients (18 vs 48 h, re-
spectively). Additionally, a significant reduction of
median hospital LOS by at least one day for febrile in-
fants < 90 days of age tested CSF EV PCR positive was
achieved compared to those tested negative (3 vs 4 days).
These findings confirm previous studies reporting a re-
duction of antimicrobial treatment duration between 30
and 50% [4, 6, 10, 13, 15, 19]. The greater extent of the
reported reduction of antimicrobial treatment duration
in our analysis may be linked to the rapid availability of
CSF EV PCR results. While the duration of the PCR in
the microbiology laboratory takes 2.5 h, the time to re-
sult depends on the pre-analytical time (time from lum-
bar tap to start of the PCR run) and the post-analytical
time (time between end of PCR run, interpretation and
reporting of the result to the clinician). Such a short
time to result of 3 to 6 h as in our study was only evalu-
ated by Archimbaud et al. and Huizing et al. [16, 17] in
CSF EV PCR positive infants before and after routine
introduction of the test.
The majority of neonates and young children < 90 days
of age presenting with fever are hospitalized in good
general condition and empirically treated for potential
sepsis, even if unlikely, awaiting negative culture results
from blood, CSF and urine for 48–72 h [24]. As the ini-
tial clinical presentation does not allow to discriminate
invasive bacterial from viral infections and enterovirus
Fig. 3 Comparison of duration of antimicrobial treatment (a) and hospital LOS (b) between tested and untested group patients. Comparison of
medians between tested group (i.e. CSF EV CSF positive and negative patients) and untested group patients using the Mann-Whitney U test. The
number in the bars indicates the median value. Abbreviations: LOS, length of stay; EV, enterovirus; CSF, cerebrospinal fluid; PCR, polymerase chain
reaction; hrs, hours; d, days
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infections are frequent in this age group, identification of
EV infection might allow to stop antimicrobial treatment
without awaiting results from bacterial cultures and dis-
charge these infants early, if in good condition. This ap-
proach is feasible in everyday practice as there is a very
low risk of concomitant bacterial infection in CSF EV
PCR positive patients in this and other reports [3, 17, 25].
Furthermore Nigrovic et al. [7] have shown that infants
older than 4 weeks with EV meningitis have a low risk for
bacterial co-infection and might be safely treated as outpa-
tients, assuming they appear to be well and are followed
up adequately.
In our study the effect of EV testing in CSF was not
yet strong enough to demonstrate a significant reduction
of hospital LOS before and after test introduction. Pos-
sible explanations for these findings are the not yet sys-
tematic introduction of the test (i.e. the attending
physician decided whether or not to perform the test),
the lack of rapid implementation (i.e. discharge of the
patient by the responsible team of physicians at bedside
as soon as the test result was available) and to a lesser
extent the non-availability of the test during the night. It
remains to be seen whether systematic testing, immedi-
ate reporting of the test result and its subsequent imple-
mentation with cessation of antimicrobial treatment in
EV positive infants, if in good general condition and
with normal urine analysis, may allow to achieve a sig-
nificant overall reduction of hospital LOS.
Significantly higher CSF leucocyte levels have been de-
scribed for CSF EV PCR positive patients [5] and could be
confirmed in our study. King et al. [6] by stratifying patients
according to presence or absence of CSF pleocytosis, dem-
onstrated significant decreases of hospital LOS in both
groups tested positive for CSF EV PCR. Nevertheless, the
absence of CSF pleocytosis in neonates with enteroviral
meningitis is a well-known phenomenon. The lack of CSF
pleocytosis in 34–77% of neonates with enteroviral menin-
gitis in previous studies [11, 12] does not allow to use CSF
pleocytosis as an indicator for enteroviral meningitis in this
age group. In fact applying the more restrictive reference
values of liquor pleocytosis according to Bonadio et al. [23]
(age < 4weeks > 22 cells/μl CSF, age 4–7 weeks > 15 cells/μl
CSF and age > 8 weeks > 5 cells/μl CSF) 8 (22%) of the EV
positive patients in our study showed absence of CSF pleo-
cytosis. Despite the low threshold for CSF pleocytosis (≥5
WBC per μl) used in this study, some young infants with
EV meningitis might have been missed. In fact, 2 out of 7
patients excluded because of lack of pleocytosis (Fig. 1)
tested CSF EV PCR positive.
Therefore, the fact that pleocytosis was the main indi-
cation to perform the test is a limitation of our study.
Other limitations of our work are its retrospective de-
sign, the small sample size and the unsystematic use of
the CSF EV PCR test in febrile infants < 90 days of age.
Conclusions
The use of rapid CSF EV PCR testing in febrile infants
< 90 days of age undergoing full sepsis evaluation leads
to a significant reduction of antimicrobial treatment dur-
ation and hospital LOS in EV positive compared to
negative patients but also to an overall reduction of anti-
microbial treatment in patients with aseptic meningitis.
These benefits of rapid CSF EV PCR testing in febrile
neonates and infants on duration of treatment and hos-
pital stay may be increased if systematic testing is intro-
duced (e.g. testing all febrile infants < 90 days of age who
undergo lumbar puncture during enteroviral season in-
dependently of pleocytosis), time to reporting of the test
result is optimized, and medical staff is instructed to
rapidly implement the positive test result on patient
management.
Abbreviations
CRP: C-reactive protein; CSF: Cerebrospinal fluid; EV: Enterovirus; LOS: Length
of stay; PCR: Polymerase chain reaction; UTI: Urinary tract infection;
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